RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-25 23:17:49 ET
RxSight, Inc. (RXST) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST
Company Participants
Oliver Moravcevic - Vice President of Investor Relations
Ronald Kurtz - President, CEO & Director
Mark Wilterding - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
RxSight Inc.
NASDAQ: RXST
RXST Trading
1.75% G/L:
$7.54 Last:
308,775 Volume:
$7.64 Open:
RXST Latest News
February 25, 2026 04:05:00 pm
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
February 11, 2026 04:10:00 pm
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
RXST Stock Data
$337,567,614
37,181,778
N/A
47
N/A
Medical Equipment & Supplies
Healthcare
US
Aliso Viejo
